SCHEMBL1315465

SCHEMBL1315465

C=C(C[SiH2]Cl)c1ccccc1C

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
ENPP3 O14638 1/20 0.38
ALPL P05186 1/20 0.38
XIAP P98170 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
ERCC5 P28715 1/20 0.37
FEN1 P39748 1/20 0.37
CTNNB1 P35222 3/20 0.36
WNT3A P56704 3/20 0.36
HPGD P15428 3/20 0.35
ELANE P08246 3/20 0.35
PLAU P00749 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.34
TYK2 P29597 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10899148 0.78 MAOA (0.56) MAOAMAOBERCC5FEN1CTNNB1
SCHEMBL2313481 0.75 MAOA (0.58) MAOAMAOBERCC5FEN1CTNNB1
SCHEMBL9255791 0.75 MAOA (0.58) MAOAMAOBERCC5FEN1CTNNB1
SCHEMBL919815 0.74 MAOA (0.43) MAOAMAOBERCC5FEN1HPGD
SCHEMBL7197694 0.72 MAOA (0.55) MAOAMAOBERCC5FEN1CTNNB1
SCHEMBL15966565 0.72 MAOA (0.59) MAOAMAOBL3MBTL1ERCC5FEN1
SCHEMBL6546767 0.71 MAOA (0.53) MAOAMAOBHPGDKMT2ASMN1; SMN2
SCHEMBL11015523 0.71 MAOA (0.53) MAOAMAOBL3MBTL1ERCC5FEN1
SCHEMBL3113556 0.70 MAOA (0.47) MAOAMAOBENPP3ALPLXIAP
SCHEMBL2771852 0.69 MAOA (0.50) MAOAMAOBERCC5FEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163950-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-04-24 US disclosed
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2011-11-10 US disclosed
US-8008521-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2011-08-30 US disclosed
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2009-03-26 US disclosed
US-7459577-B2 Reacting a chlorosilane with grignard reagent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2008-12-02 US disclosed
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X MAOA 962/4885MAOB 2445/4885ENPP3 3715/4885
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X MAOA 962/4885MAOB 2445/4885ENPP3 3715/4885
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes MLX, HAX1, GRIA3 MAOA 1673/4885MAOB 2991/4885ENPP3 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.